Sign in Pull a receipt

PYXS

Pyxis Oncology, Inc.

Healthcare · Biotechnology

$61.76 sample

-0.70 (-1.12%) 1D

Market cap

$238.4B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-21

Alerts

8

Price$61.76 -7.30% 3M daily closessample

67.4361.01

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider buy: Director
Oct 21SECDEF 14A filed
Oct 16INSInsider sell: Director
Oct 08INSInsider buy: Director
Oct 05INSInsider sell: EVP, Operations
Sep 28INSInsider sell: Chief Executive Officer
Sep 18INSInsider buy: EVP, Operations
Sep 14SEC8-K filed: material event

Sign up to see the real PYXS record →

Company facts

SEC EDGAR registration

Name: Pyxis Oncology, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -59sample, -100 to +100
Reporting currency: USD

Who is positioning in PYXS

sample

Insiders: 35 insider transactions over 90 days, net selling, $289.4M
Congress: 3 members traded over 90 days
Institutions · 13F: 38 funds hold $5.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.8B +17.9% y/y

Q4 2024Q3 2026

Inventory$5.8B +10.8% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +10.2% y/y

Q4 2024Q3 2026

Total debt$11.7B +15.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $24.4B -2.5% 3M
Sample peer B: $90.4B -2.5% 3M
Sample peer C: $78.3B -1.9% 3M
Sample peer D: $44.6B +6.2% 3M
Sample peer E: $98.9B -11.4% 3M